Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells
Authors
Keywords
Plumbagin, ARF1, NSCLC, ROS, Immune response
Journal
PHARMACOLOGICAL RESEARCH
Volume 169, Issue -, Pages 105656
Publisher
Elsevier BV
Online
2021-05-06
DOI
10.1016/j.phrs.2021.105656
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice
- (2020) Guohao Wang et al. Nature Communications
- Design and Synthesis of Arf1-Targeting γ-Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma
- (2020) Yen Vo-Hoang et al. Cells
- The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective
- (2020) Cristina Casalou et al. Frontiers in Cell and Developmental Biology
- Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway
- (2020) Wen-Jun Wang et al. PHARMACOLOGICAL RESEARCH
- Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis
- (2020) Ze-Bo Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Plumbagin Ameliorates Collagen-Induced Arthritis by Regulating Treg/Th17 Cell Imbalances and Suppressing Osteoclastogenesis
- (2019) Tingyu Wang et al. Frontiers in Immunology
- Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer
- (2019) Patrick R. Halliday et al. Current Oncology Reports
- Analysis of status and countermeasures of cancer incidence and mortality in China
- (2019) Chunchun Wu et al. Science China-Life Sciences
- Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction
- (2019) Anna Kawiak et al. JOURNAL OF NATURAL PRODUCTS
- Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds
- (2019) Patrizia Limonta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer
- (2019) Elaine Lai-Han Leung et al. INTERNATIONAL JOURNAL OF CANCER
- Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress
- (2019) Sarayu A. Pai et al. BIOMEDICINE & PHARMACOTHERAPY
- Crosstalk between Calcium and ROS in Pathophysiological Conditions
- (2019) Simona Feno et al. Oxidative Medicine and Cellular Longevity
- Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA
- (2019) Tingting Li et al. Drug Design Development and Therapy
- Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection
- (2019) Elizabeth Varghese et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Plumbagin ameliorates liver fibrosis via a ROS-mediated NF-кB signaling pathway in vitro and in vivo
- (2019) Yongxin Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report
- (2019) Cheng Fang et al. BMC Medical Genomics
- Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer
- (2019) Huanlan Sa et al. OncoTargets and Therapy
- MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3′UTR and predicts poor survival in non-small cell lung cancer
- (2019) Fu-Gang Duan et al. Cell Death & Disease
- Plumbagin Triggers ER Stress-Mediated Apoptosis in Prostate Cancer Cells via Induction of ROS
- (2018) Hang Huang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling
- (2018) Ying-Ya Cao et al. Cell Death & Disease
- The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells
- (2018) Samia S. Messeha et al. PLoS One
- Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells
- (2018) Umasankar De et al. FOOD AND CHEMICAL TOXICOLOGY
- Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells
- (2018) Wei Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeted therapies for advanced non-small cell lung cancer
- (2018) Xiaojuan Ai et al. Oncotarget
- Redox signaling and unfolded protein response coordinate cell fate decisions under ER stress
- (2018) Zhe Zhang et al. Redox Biology
- Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi-1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP
- (2017) Xiaoyang Kong et al. ONCOLOGY REPORTS
- Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer
- (2017) Guifang Gu et al. ONCOLOGY REPORTS
- Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
- (2017) Xia Li et al. PHARMACOLOGICAL RESEARCH
- Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation
- (2016) Elaine Lai-Han Leung et al. ANTIOXIDANTS & REDOX SIGNALING
- Plumbagin protects against hydrogen peroxide-induced neurotoxicity by modulating NF-κB and Nrf-2
- (2016) Wang Kuan-hong et al. Archives of Medical Science
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antimicrobial activity of plumbagin, a naturally occurring naphthoquinone from Plumbago rosea, against Staphylococcus aureus and Candida albicans
- (2016) Sweatha V. Nair et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- STAT3 regulated ARF expression suppresses prostate cancer metastasis
- (2015) Jan Pencik et al. Nature Communications
- Calcium and ROS: A mutual interplay
- (2015) Agnes Görlach et al. Redox Biology
- ROS Function in Redox Signaling and Oxidative Stress
- (2014) Michael Schieber et al. CURRENT BIOLOGY
- Oxidative stress-induced mutagenesis in single-strand DNA occurs primarily at cytosines and is DNA polymerase zeta-dependent only for adenines and guanines
- (2013) N. P. Degtyareva et al. NUCLEIC ACIDS RESEARCH
- ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein
- (2011) P-L Boulay et al. ONCOGENE
- Plumbagin, a Medicinal Plant–Derived Naphthoquinone, Is a Novel Inhibitor of the Growth and Invasion of Hormone-Refractory Prostate Cancer
- (2008) Moammir H. Aziz et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started